Aster Capital Management (DIFC) Ltd
Position in PCRX — Pacira BioSciences, Inc.
CIK 2040915
DUBAI, C0
Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,124
-$2,017 QoQ
Shares Held
202
-36.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#210
of 251 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aster Capital Management (DIFC) Ltd holds $908,587 across 11 Drug Manufacturers - Specialty & Generic names. PCRX ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,078 | $584,092 | |
| 2 | DERM |
Journey Medical Corp
|
30,720 | $217,497 | |
| 3 | VTRS |
Viatris Inc
|
3,589 | $56,993 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
288 | $13,613 | |
| 5 | LQDA |
Liquidia Corp
|
110 | $8,770 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
393 | $7,058 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
This page
|
202 | $5,124 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
134 | $4,850 |
All Filings in PCRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,124 | 202 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,141 | 316 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $5,066 | 212 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||